Bladder Cancer
Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound.
April 12, 2022
Standardized care pathways for patients with suspected urinary bladder cancer: the Swedish experience.
April 11, 2022
Expression of RPL9 predicts the recurrence of non-muscle invasive bladder cancer with BCG therapy.
April 8, 2022
Interactions Between Smoking and Single Nucleotide Polymorphisms Influence Urothelial Cancer Risk - Expert Commentary
April 7, 2022
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma.
April 7, 2022
Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer.
April 7, 2022
The learning curve in bladder MRI using VI-RADS assessment score during an interactive dedicated training program.
April 5, 2022
Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer.
April 4, 2022
Cognitive function in patients undergoing cystectomy for bladder cancer - results from a prospective observational study.
April 4, 2022
Reduced-dose bacillus Calmette-Guérin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre
April 1, 2022